<HTML>
<HEAD>
<TITLE>ICN Pharmaceuticals, Inc. Form S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="2">As filed with the Securities and
Exchange Commission on April 5, 2002</FONT>

<DIV align="right"><FONT size="2">Registration Statement No.&nbsp;333-</FONT></DIV>

<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">




<P align="center"><FONT size="3"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT>
<DIV align="center"><FONT size="2"><B>Washington, D.C. 20549</B></FONT></DIV>

<P align="center"><FONT size="2"><B>__________________</B></FONT>

<P align="center"><FONT size="3"><B>FORM S-8</B></FONT>
<DIV align="center"><FONT size="2"><B>REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</B></FONT></DIV>

<P align="center"><FONT size="2"><B>__________________</B></FONT>

<P align="center"><FONT size="2">ICN PHARMACEUTICALS, INC.<BR>
(Exact name of registrant as specified in its charter)</FONT>

<P align="center"><FONT size="2">Delaware<BR>
(State or other jurisdiction of incorporation or organization)</FONT>

<P align="center"><FONT size="2">33-0628076<BR>
(I.R.S. Employer Identification No.)</FONT>

<P align="center"><FONT size="2">3300 Hyland Avenue<BR>
Costa Mesa, California 92626</FONT>
<DIV align="center"><FONT size="2">(Address of principal executive offices, including zip code)</FONT></DIV>

<P align="center"><FONT size="2"><B>ICN PHARMACEUTICALS, INC. LONG-TERM INCENTIVE PLAN</B></FONT>
<DIV align="center"><FONT size="2">(Full title of the Plan)</FONT></DIV>

<P align="center"><FONT size="2">GREGORY KEEVER, ESQ.<BR>
Executive Vice President, General Counsel<BR>
and Corporate Secretary<BR>
ICN Pharmaceuticals, Inc.<BR>
3300 Hyland Avenue, Costa Mesa, California 92626<BR>
(714)&nbsp;545-0100<BR>
(Name and address of agent for service)<BR>
(Telephone number, including area code, of agent for service)</FONT>

<P align="center"><FONT size="2"><I>with copies to</I></FONT>

<P align="center"><FONT size="2">CAROL B. STUBBLEFIELD, ESQ.<BR>
Coudert Brothers LLP<BR>
1114 Avenue of the Americas<BR>
New York, New York 10036-7703<BR>
(212)&nbsp;626-4400</FONT>

<P align="center"><FONT size="2"><B>__________________</B></FONT>

<P align="center"><FONT size="2"><B>CALCULATION OF REGISTRATION FEE</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="33%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="20%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD colspan="15" nowrap align="center"><HR size="4" noshade></TD>
</TR>
<TR valign="bottom">
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Proposed</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Proposed</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">Title of</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1">Amount</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">maximum</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">maximum</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Amount of</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">securities to</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1">to be</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">offering price</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">aggregate</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">registration</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">be registered</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1">registered(1)</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">per share(2)</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">offering price(2)</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">fee</FONT></TD>
</TR>
<TR valign="bottom">
        <TD colspan="15" nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
        <TD nowrap valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock, $.01
par value per share</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
500,000 shares (3)
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">31.37
</FONT></TD>
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">15,685,000
</FONT></TD>
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">1,443</FONT></TD>
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD colspan="15" nowrap align="center"><HR size="4" noshade></TD>
</TR>
</TABLE>
</CENTER>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Pursuant to Rule&nbsp;416(a) of the Securities Act of 1933, this Registration
Statement also registers such indeterminate number of additional shares as may
become issuable in connection with share splits, share dividends or similar
transactions.</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Estimated solely for the purpose of determining the registration fee
pursuant to Rule&nbsp;457(h) of the Securities Act of 1933, based upon the average
of the high and low prices of the Registrant&#146;s Common Stock as reported by the
New York Stock Exchange on April&nbsp;1, 2002.</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(3)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Represents additional shares available for grants under the Registrant&#146;s
Long-Term Incentive Plan as of April 5, 2002.</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>



<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;3. Incorporation of Certain Documents by Reference</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;4. Description of Securities</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;5. Interests of Named Experts and Counsel</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;6. Indemnification of Directors and Officers</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;7. Exemption from Registration Claimed</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;8. Exhibits</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;9.  Undertakings</A></TD></TR>
<TR><TD colspan="9"><A HREF="#008">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#009">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="a80589ex5-1.htm">EXHIBIT 5.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="a80589ex23-1.htm">EXHIBIT 23.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<P align="center"><FONT size="2"><B>EXPLANATORY NOTE</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement relates to 500,000 shares of the Registrant&#146;s
Common Stock, $0.01 par value per share, issuable pursuant to its Long-Term
Stock Incentive Plan (the &#147;Plan&#148;). On June&nbsp;23, 1999, the Registrant filed an
initial Form&nbsp;S-8 Registration Statement (file no. 333-81383) to register
600,000 shares of Common Stock issuable pursuant to its Plan. The contents of
such Registration Statement are incorporated herein by reference except as set
forth below. As permitted by the rules of the Securities and Exchange
Commission, this Registration Statement omits the information
specified in Part I of Form&nbsp;S-8.
</FONT>
<!-- link1 "PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT" -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="center"><FONT size="2"><B>PART II</B></FONT>

<P align="center"><FONT size="2"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></FONT>

<!-- link2 "Item&nbsp;3. Incorporation of Certain Documents by Reference" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;3. Incorporation of Certain Documents by Reference</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ICN Pharmaceuticals, Inc. (&#147;ICN&#148;) hereby incorporates herein by reference
the following documents which are on file with the Securities and Exchange
Commission:
</FONT>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="1%" nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
        <TD width="99%"></TD>
</TR>
<TR valign="top">
        <TD nowrap><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">(a)&nbsp;Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31,
2001, dated March&nbsp;27, 2002;</FONT></TD>
</TR>
<TR>
        <TD nowrap><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD nowrap><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">(b)&nbsp;the description of the Common Stock contained in the Registration
Statement on Form&nbsp;8-A, dated November&nbsp;10, 1994.</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, all documents and other reports filed by ICN, respectively,
pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of the Exchange Act that are
filed subsequent to the date hereof and prior to the filing of a post-effective
amendment which indicates that all securities offered hereby have been sold or
which deregisters all securities then remaining unsold, shall be deemed to be
incorporated herein by reference and to be part hereof from the respective date
of filing of each such document.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement contained herein or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes hereof to the
extent that a statement contained in any other subsequently filed document
incorporated by reference modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part hereof.
</FONT>
<!-- link2 "Item&nbsp;4. Description of Securities" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;4. Description of Securities</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</FONT>
<!-- link2 "Item&nbsp;5. Interests of Named Experts and Counsel" -->
<DIV align="left"><A NAME="003"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;5. Interests of Named Experts and Counsel</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the Common Stock offered hereby will be passed upon for
the Registrant by Coudert Brothers LLP, New York, New York. Gregory Keever,
Esq., Executive Vice President, General Counsel and Secretary of the
Registrant, is a member of the law firm of Coudert Brothers LLP.
</FONT>
<!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers" -->
<DIV align="left"><A NAME="004"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;6. Indemnification of Directors and Officers</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145 of the General Corporation Law of Delaware empowers a
corporation to indemnify any person who was or is a party or is threatened to
be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative by reason
of the fact that he or she is or was a director, officer, employee or agent of
the corporation or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation or enterprise.
Depending on the character of the proceeding, a corporation may indemnify
against expenses
</FONT>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P><FONT size="2">(including attorneys&#146; fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred in connection with such action,
suit or proceeding if the person indemnified acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to the best
interests of the corporation, and with respect to any criminal action or
proceeding, had no cause to believe his or her conduct was unlawful. In the
case of an action by or in the right of the corporation, no indemnification may
be made in respect to any claim, issue or matter as to which such person shall
have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or the court in which such action or suit was
brought shall determine that despite the adjudication of liability such person
is fairly and reasonably entitled to indemnity for such expenses which the
court shall deem proper.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145 further provides that to the extent a director or officer of a
corporation has been successful in the defense of any action, suit or
proceeding referred to above or in the defense of any claim, issue or matter
therein, he or she shall be indemnified against expenses (including attorneys&#146;
fees) actually and reasonably incurred by him or her in connection therewith.
However, if the director or officer is not successful in the defense of any
action, suit or proceeding as referred to above or in the defense of any claim,
issue or matter therein, he shall only be indemnified by the corporation as
authorized in the specific case upon a determination that indemnification is
proper because he or she met the applicable standard set forth above as
determined by a majority of the disinterested Board of Directors or by the
stockholders.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registrant&#146;s bylaws provide indemnification to its officers and
directors against liability they may incur in their capacity as such, which
indemnification is similar to that provided by Section&nbsp;145, unless a
determination is reasonably and promptly made by a majority of the
disinterested Board of Directors that the indemnitee acted in bad faith and in
a manner that the indemnitee did not believe to be in or not opposed to the
best interests of the Registrant, or, with respect to any criminal proceeding,
that the indemnitee believed or had reasonable cause to believe that his or her
conduct was unlawful.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registrant carries directors&#146; and officers&#146; liability insurance,
covering losses up to $10,000,000 (subject to a $250,000 deductible and a 20%
co-insurance on the first $5&nbsp;million). The Registrant, as a matter of policy,
enters into indemnification agreements with its directors and officers
indemnifying them against liability they may incur in their capacity as such.
The indemnification agreements require no specific standard of conduct for
indemnification and make no distinction between civil and criminal proceedings,
except in proceedings where the dishonesty of an indemnitee is alleged. Such
indemnification is not available if an indemnitee is adjudicated to have acted
in a deliberately dishonest manner with actual dishonest purpose and intent
where such acts were material to the adjudicated proceeding. Additionally, the
indemnity agreements do not provide indemnification for any claim against an
indemnitee where the claim is based upon the indemnitee obtaining personal
advantage or profit to which he or she was not legally entitled, the claim is
for an accounting of profits made in connection with a violation of Section
16(b) of the Securities Exchange Act of 1934, or similar state law provision,
or the claim was brought about or contributed to by the dishonesty of the
indemnitee.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;102(b)(7) of the Delaware General Corporation Law, as amended,
permits a corporation to include in its certificate of incorporation a
provision eliminating or limiting the personal liability of a director to the
corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, provided that such provision shall not eliminate or limit
the liability of a director (i)&nbsp;for any breach of the directors&#146; duty of
loyalty to the corporation or its stockholders, (ii)&nbsp;for acts or omissions not
in good faith or which involve intentional misconduct or a knowing violation of
law, (iii)&nbsp;under Section&nbsp;174 of the Delaware General Corporation Law (relating
to unlawful payment of dividend and unlawful stock purchase and redemption), or
(iv)&nbsp;for any transaction from which the director derived an improper personal
benefit. The Registrant has provided in its certificate of incorporation, as
amended, that its directors shall be exculpated from liability as provided
under Section&nbsp;102(b)(7).
</FONT>
<P align="center"><FONT size="2">2
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing summaries are necessarily subject to the complete text of
the Delaware General Corporation Law, the Registrant&#146;s Certificate of
Incorporation and the agreements referred to above and are qualified in their
entirety by reference thereto.
</FONT>
<!-- link2 "Item&nbsp;7. Exemption from Registration Claimed" -->
<DIV align="left"><A NAME="005"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;7. Exemption from Registration Claimed</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</FONT>
<!-- link2 "Item&nbsp;8. Exhibits" -->
<DIV align="left"><A NAME="006"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;8. Exhibits</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">&nbsp;&nbsp;4.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Amended and Restated Certificate of Incorporation of
Registrant, previously filed as Exhibit&nbsp;3.1 to Registration
Statement 33-84534 on Form&nbsp;S-4, which is incorporated herein by
reference, as amended by the Certificate of Merger, dated November
10, 1994, of ICN Pharmaceuticals, Inc., SPI Pharmaceuticals, Inc.
and Viratek, Inc. with and into ICN Merger Corp. previously filed as
Exhibit&nbsp;4.1 to Registration Statement No.&nbsp;333-08179 on Form&nbsp;S-3,
which is incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">&nbsp;&nbsp;4.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Bylaws of the Registrant previously filed as Exhibit&nbsp;3.2 to
Registration Statement No.&nbsp;33-84534 on Form&nbsp;S-4, which is
incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">&nbsp;&nbsp;4.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Form of Rights Agreement, dated as of November&nbsp;2, 1994,
between the Registrant and American Stock Transfer &#038; Trust Company,
as trustee, previously filed as Exhibit&nbsp;4.3 to the Registrant&#146;s
Registration Statement on Form&nbsp;8-A, dated November&nbsp;10, 1994, which
is incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">&nbsp;&nbsp;4.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ICN Pharmaceuticals, Inc. Long-Term Incentive Plan previously
filed as Exhibit&nbsp;10.1 to the Registrant&#146;s Quarterly Report on Form&nbsp;10-Q for the
quarter ended June&nbsp;30, 1998, and incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">&nbsp;&nbsp;5.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of Coudert Brothers LLP regarding the legality of
shares of Common Stock covered by the Registration Statement.</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Independent Accountants.</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Coudert Brothers LLP (included in Exhibit&nbsp;5.1).</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">24.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Powers of Attorney (included on signature pages of this Registration Statement).</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">*Incorporated by Reference.
</FONT>
<P align="center"><FONT size="2">3
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link2 "Item&nbsp;9.  Undertakings" -->
<DIV align="left"><A NAME="007"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;9.  Undertakings</B></FONT>


<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes:
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="4%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="91%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">(1)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
to file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement to
include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement;</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">(2)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
that, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide </I>offering thereof; and</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="right" valign="top"><FONT size="2">(3)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
to remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold
at the termination of the offering.</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s
annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is
incorporated by reference in the registration statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions described in Item&nbsp;6 hereof, or otherwise,
the Registrant has been advised that, in the opinion of the Commission, such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities
being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by them is
against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.
</FONT>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="008"></A></DIV>
<P align="center"><FONT size="2"><B>SIGNATURES</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form&nbsp;S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Costa Mesa, California, on
April&nbsp;2, 2002.
</FONT>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR>
        <TD width="50%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="49%">&nbsp;</TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD colspan="2"><FONT size="2">ICN PHARMACEUTICALS, INC.<BR>
Registrant</FONT></TD>
</TR>

<TR><TD>&nbsp;<BR>&nbsp;</TD></TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">By:&nbsp;</FONT></TD>
        <TD><FONT size="2">/s/ Milan Panic</FONT></TD>
</TR>
<TR>
        <TD colspan="2"><FONT size="1">&nbsp;</FONT></TD>
        <TD><HR size="1" noshade color="#000000"></TD>
</TR>
<TR>
        <TD>&nbsp;</TD>
        <TD colspan="2"><FONT size="2">
Name:&nbsp;&nbsp;Milan Panic<BR>
Title:&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</FONT></TD>
</TR>
</TABLE>

<P align="center"><FONT size="2"><B>POWER OF ATTORNEY</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below hereby constitutes and appoints each of John Giordani and Gregory Keever,
Esq., acting severally, his or her true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, for him or her and
in his or her name, place and stead, and in any and all capacities, to sign any
and all amendments to this Registration Statement, and to file the same with
all exhibits thereto and other documents in connection therewith with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as each such person might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents, or their
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="40%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="28%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="22%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>Signature</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1"><B>Title</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1"><B>Date</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Milan Panic<BR>
<HR size="1" noshade>
Milan Panic</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Chairman of the Board<BR>
and CEO<BR>
(Principal Executive Officer)
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;2, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ John Giordani<BR>
<HR size="1" noshade>
John Giordani</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Executive Vice President and<BR>
Chief Financial Officer<BR>
(Principal Financial and<BR>
Accounting Officer)
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>

<TD nowrap align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April
2, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Adam Jerney<BR>
<HR size="1" noshade>
Adam Jerney</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director, President and<BR>
Chief Operating Officer
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;2, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Norman Barker<BR>
<HR size="1" noshade>
Norman Barker, Jr.</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;1, 2002</FONT></DIV></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="40%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="28%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="22%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>Signature</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1"><B>Title</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1"><B>Date</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Birch E. Bayh<BR>
<HR size="1" noshade>
Senator Birch E. Bayh, Esq.</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;1, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2"><HR size="1" noshade>
Edward A. Burkhardt</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">_____, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/
Alan
F. Charles<BR>
<HR size="1" noshade>
Alan F. Charles</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April
2, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/
Ronald R. Fogleman<BR>
<HR size="1" noshade>
Ronald R. Fogleman</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April
2, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2"><HR size="1" noshade>
Roger Guillemin, M.D., Ph.D.</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">_____, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>

<TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">&nbsp;<BR>
<HR size="1" noshade>Jean-Francois Kurz</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">_____, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Steven J. Lee<BR>
<HR size="1" noshade>
Steven J. Lee</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;1, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">/s/ Stephen D. Moses<BR>
<HR size="1" noshade>
Stephen D. Moses</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">April&nbsp;1, 2002</FONT></DIV></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2"><HR size="1" noshade>
Rosemary Tomich</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">
Director
</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">_____, 2002</FONT></DIV></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="009"></A></DIV>
<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B></FONT>


<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="5%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="90%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;4.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Amended and Restated Certificate of Incorporation of
Registrant, previously filed as Exhibit&nbsp;3.1 to Registration
Statement 33-84534 on Form&nbsp;S-4, which is incorporated herein by
reference, as amended by the Certificate of Merger, dated November
10, 1994, of ICN Pharmaceuticals, Inc., SPI Pharmaceuticals, Inc.
and Viratek, Inc. with and into ICN Merger Corp. previously filed as
Exhibit&nbsp;4.1 to Registration Statement No.&nbsp;333-08179 on Form&nbsp;S-3,
which is incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;4.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Bylaws of the Registrant previously filed as Exhibit&nbsp;3.2 to
Registration Statement No.&nbsp;33-84534 on Form&nbsp;S-4, which is
incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;4.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Form of Rights Agreement, dated as of November&nbsp;2, 1994,
between the Registrant and American Stock Transfer &#038; Trust Company,
as trustee, previously filed as Exhibit&nbsp;4.3 to the Registrant&#146;s
Registration Statement on Form&nbsp;8-A, dated November&nbsp;10, 1994, which
is incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;4.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ICN Pharmaceuticals, Inc. Long-Term Incentive Plan previously
filed as Exhibit&nbsp;10.1 to the Registrant&#146;s Quarterly Report on Form&nbsp;10-Q for the
quarter ended June&nbsp;30, 1998, and incorporated herein by reference.*</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;5.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of Coudert Brothers LLP regarding the legality of
shares of Common Stock covered by the Registration Statement.</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Independent Accountants.</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Coudert Brothers LLP (included in Exhibit&nbsp;5.1).</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="left" valign="top"><FONT size="2">24.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Powers of Attorney (included on signature pages of this Registration Statement).</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P><FONT size="2">*Incorporated by Reference.
</FONT>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "a80589s-8.htm", "description": "FORM S-8", "secsgml_size_bytes": 45828}]
{"company-data": {"conformed-name": "ICN PHARMACEUTICALS INC", "cik": "0000930184", "assigned-sic": "2834", "irs-number": "330628076", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-85572", "film-number": "02602468"}, "business-address": {"street1": "3300 HYLAND AVE", "city": "COSTA MESA", "state": "CA", "zip": "92626", "phone": "7145450100"}, "mail-address": {"street1": "3300 HYLAND AVE", "city": "COSTA MESA", "state": "CA", "zip": "92626"}, "former-company": {"former-conformed-name": "ICN MERGER CORP", "date-changed": "19940915"}}
ICN Pharmaceuticals, Inc. Form S-8
Table of Contents
As filed with the Securities and
Exchange Commission on April 5, 2002
Registration Statement No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
__________________
ICN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
33-0628076
(I.R.S. Employer Identification No.)
3300 Hyland Avenue
Costa Mesa, California 92626
(Address of principal executive offices, including zip code)
ICN PHARMACEUTICALS, INC. LONG-TERM INCENTIVE PLAN
(Full title of the Plan)
GREGORY KEEVER, ESQ.
Executive Vice President, General Counsel
and Corporate Secretary
ICN Pharmaceuticals, Inc.
3300 Hyland Avenue, Costa Mesa, California 92626
(714) 545-0100
(Name and address of agent for service)
(Telephone number, including area code, of agent for service)
with copies to
CAROL B. STUBBLEFIELD, ESQ.
Coudert Brothers LLP
1114 Avenue of the Americas
New York, New York 10036-7703
(212) 626-4400
__________________
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Title of
Amount
maximum
maximum
Amount of
securities to
to be
offering price
aggregate
registration
be registered
registered(1)
per share(2)
offering price(2)
fee
Common Stock, $.01
par value per share
500,000 shares (3)
$
31.37
$
15,685,000
$
1,443
(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, this Registration
Statement also registers such indeterminate number of additional shares as may
become issuable in connection with share splits, share dividends or similar
transactions.
(2)
Estimated solely for the purpose of determining the registration fee
pursuant to Rule 457(h) of the Securities Act of 1933, based upon the average
of the high and low prices of the Registrant's Common Stock as reported by the
New York Stock Exchange on April 1, 2002.
(3)
Represents additional shares available for grants under the Registrant's
Long-Term Incentive Plan as of April 5, 2002.
TABLE OF CONTENTS
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Certain Documents by Reference
Item 4. Description of Securities
Item 5. Interests of Named Experts and Counsel
Item 6. Indemnification of Directors and Officers
Item 7. Exemption from Registration Claimed
Item 8. Exhibits
Item 9.  Undertakings
SIGNATURES
EXHIBIT INDEX
EXHIBIT 5.1
EXHIBIT 23.1
Table of Contents
EXPLANATORY NOTE
This Registration Statement relates to 500,000 shares of the Registrant's
Common Stock, $0.01 par value per share, issuable pursuant to its Long-Term
Stock Incentive Plan (the "Plan"). On June 23, 1999, the Registrant filed an
initial Form S-8 Registration Statement (file no. 333-81383) to register
600,000 shares of Common Stock issuable pursuant to its Plan. The contents of
such Registration Statement are incorporated herein by reference except as set
forth below. As permitted by the rules of the Securities and Exchange
Commission, this Registration Statement omits the information
specified in Part I of Form S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Certain Documents by Reference
ICN Pharmaceuticals, Inc. ("ICN") hereby incorporates herein by reference
the following documents which are on file with the Securities and Exchange
Commission:
(a) Annual Report on Form 10-K for the fiscal year ended December 31,
2001, dated March 27, 2002;
(b) the description of the Common Stock contained in the Registration
Statement on Form 8-A, dated November 10, 1994.
In addition, all documents and other reports filed by ICN, respectively,
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act that are
filed subsequent to the date hereof and prior to the filing of a post-effective
amendment which indicates that all securities offered hereby have been sold or
which deregisters all securities then remaining unsold, shall be deemed to be
incorporated herein by reference and to be part hereof from the respective date
of filing of each such document.
Any statement contained herein or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes hereof to the
extent that a statement contained in any other subsequently filed document
incorporated by reference modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part hereof.
Item 4. Description of Securities
Not applicable.
Item 5. Interests of Named Experts and Counsel
The validity of the Common Stock offered hereby will be passed upon for
the Registrant by Coudert Brothers LLP, New York, New York. Gregory Keever,
Esq., Executive Vice President, General Counsel and Secretary of the
Registrant, is a member of the law firm of Coudert Brothers LLP.
Item 6. Indemnification of Directors and Officers
Section 145 of the General Corporation Law of Delaware empowers a
corporation to indemnify any person who was or is a party or is threatened to
be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative by reason
of the fact that he or she is or was a director, officer, employee or agent of
the corporation or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation or enterprise.
Depending on the character of the proceeding, a corporation may indemnify
against expenses
Table of Contents
(including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred in connection with such action,
suit or proceeding if the person indemnified acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to the best
interests of the corporation, and with respect to any criminal action or
proceeding, had no cause to believe his or her conduct was unlawful. In the
case of an action by or in the right of the corporation, no indemnification may
be made in respect to any claim, issue or matter as to which such person shall
have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or the court in which such action or suit was
brought shall determine that despite the adjudication of liability such person
is fairly and reasonably entitled to indemnity for such expenses which the
court shall deem proper.
Section 145 further provides that to the extent a director or officer of a
corporation has been successful in the defense of any action, suit or
proceeding referred to above or in the defense of any claim, issue or matter
therein, he or she shall be indemnified against expenses (including attorneys'
fees) actually and reasonably incurred by him or her in connection therewith.
However, if the director or officer is not successful in the defense of any
action, suit or proceeding as referred to above or in the defense of any claim,
issue or matter therein, he shall only be indemnified by the corporation as
authorized in the specific case upon a determination that indemnification is
proper because he or she met the applicable standard set forth above as
determined by a majority of the disinterested Board of Directors or by the
stockholders.
The Registrant's bylaws provide indemnification to its officers and
directors against liability they may incur in their capacity as such, which
indemnification is similar to that provided by Section 145, unless a
determination is reasonably and promptly made by a majority of the
disinterested Board of Directors that the indemnitee acted in bad faith and in
a manner that the indemnitee did not believe to be in or not opposed to the
best interests of the Registrant, or, with respect to any criminal proceeding,
that the indemnitee believed or had reasonable cause to believe that his or her
conduct was unlawful.
The Registrant carries directors' and officers' liability insurance,
covering losses up to $10,000,000 (subject to a $250,000 deductible and a 20%
co-insurance on the first $5 million). The Registrant, as a matter of policy,
enters into indemnification agreements with its directors and officers
indemnifying them against liability they may incur in their capacity as such.
The indemnification agreements require no specific standard of conduct for
indemnification and make no distinction between civil and criminal proceedings,
except in proceedings where the dishonesty of an indemnitee is alleged. Such
indemnification is not available if an indemnitee is adjudicated to have acted
in a deliberately dishonest manner with actual dishonest purpose and intent
where such acts were material to the adjudicated proceeding. Additionally, the
indemnity agreements do not provide indemnification for any claim against an
indemnitee where the claim is based upon the indemnitee obtaining personal
advantage or profit to which he or she was not legally entitled, the claim is
for an accounting of profits made in connection with a violation of Section
16(b) of the Securities Exchange Act of 1934, or similar state law provision,
or the claim was brought about or contributed to by the dishonesty of the
indemnitee.
Section 102(b)(7) of the Delaware General Corporation Law, as amended,
permits a corporation to include in its certificate of incorporation a
provision eliminating or limiting the personal liability of a director to the
corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, provided that such provision shall not eliminate or limit
the liability of a director (i) for any breach of the directors' duty of
loyalty to the corporation or its stockholders, (ii) for acts or omissions not
in good faith or which involve intentional misconduct or a knowing violation of
law, (iii) under Section 174 of the Delaware General Corporation Law (relating
to unlawful payment of dividend and unlawful stock purchase and redemption), or
(iv) for any transaction from which the director derived an improper personal
benefit. The Registrant has provided in its certificate of incorporation, as
amended, that its directors shall be exculpated from liability as provided
under Section 102(b)(7).
2
Table of Contents
The foregoing summaries are necessarily subject to the complete text of
the Delaware General Corporation Law, the Registrant's Certificate of
Incorporation and the agreements referred to above and are qualified in their
entirety by reference thereto.
Item 7. Exemption from Registration Claimed
Not applicable.
Item 8. Exhibits
4.1
Amended and Restated Certificate of Incorporation of
Registrant, previously filed as Exhibit 3.1 to Registration
Statement 33-84534 on Form S-4, which is incorporated herein by
reference, as amended by the Certificate of Merger, dated November
10, 1994, of ICN Pharmaceuticals, Inc., SPI Pharmaceuticals, Inc.
and Viratek, Inc. with and into ICN Merger Corp. previously filed as
Exhibit 4.1 to Registration Statement No. 333-08179 on Form S-3,
which is incorporated herein by reference.*
4.2
Bylaws of the Registrant previously filed as Exhibit 3.2 to
Registration Statement No. 33-84534 on Form S-4, which is
incorporated herein by reference.*
4.3
Form of Rights Agreement, dated as of November 2, 1994,
between the Registrant and American Stock Transfer & Trust Company,
as trustee, previously filed as Exhibit 4.3 to the Registrant's
Registration Statement on Form 8-A, dated November 10, 1994, which
is incorporated herein by reference.*
4.4
ICN Pharmaceuticals, Inc. Long-Term Incentive Plan previously
filed as Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q for the
quarter ended June 30, 1998, and incorporated herein by reference.*
5.1
Opinion of Coudert Brothers LLP regarding the legality of
shares of Common Stock covered by the Registration Statement.
23.1
Consent of Independent Accountants.
23.2
Consent of Coudert Brothers LLP (included in Exhibit 5.1).
24.1
Powers of Attorney (included on signature pages of this Registration Statement).
*Incorporated by Reference.
3
Table of Contents
Item 9.  Undertakings
The undersigned Registrant hereby undertakes:
(1)
to file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement to
include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement;
(2)
that, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time
shall be deemed to be the initial
bona fide
offering thereof; and
(3)
to remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold
at the termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the registration statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions described in Item 6 hereof, or otherwise,
the Registrant has been advised that, in the opinion of the Commission, such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities
being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by them is
against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Costa Mesa, California, on
April 2, 2002.
ICN PHARMACEUTICALS, INC.
Registrant
By:
/s/ Milan Panic
Name:  Milan Panic
Title:    Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below hereby constitutes and appoints each of John Giordani and Gregory Keever,
Esq., acting severally, his or her true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, for him or her and
in his or her name, place and stead, and in any and all capacities, to sign any
and all amendments to this Registration Statement, and to file the same with
all exhibits thereto and other documents in connection therewith with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as each such person might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents, or their
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
Signature
Title
Date
/s/ Milan Panic
Milan Panic
Chairman of the Board
and CEO
(Principal Executive Officer)
April 2, 2002
/s/ John Giordani
John Giordani
Executive Vice President and
Chief Financial Officer
(Principal Financial and
Accounting Officer)
April
2, 2002
/s/ Adam Jerney
Adam Jerney
Director, President and
Chief Operating Officer
April 2, 2002
/s/ Norman Barker
Norman Barker, Jr.
Director
April 1, 2002
Table of Contents
Signature
Title
Date
/s/ Birch E. Bayh
Senator Birch E. Bayh, Esq.
Director
April 1, 2002
Edward A. Burkhardt
Director
_____, 2002
/s/
Alan
F. Charles
Alan F. Charles
Director
April
2, 2002
/s/
Ronald R. Fogleman
Ronald R. Fogleman
Director
April
2, 2002
Roger Guillemin, M.D., Ph.D.
Director
_____, 2002
Jean-Francois Kurz
Director
_____, 2002
/s/ Steven J. Lee
Steven J. Lee
Director
April 1, 2002
/s/ Stephen D. Moses
Stephen D. Moses
Director
April 1, 2002
Rosemary Tomich
Director
_____, 2002
Table of Contents
EXHIBIT INDEX
4.1
Amended and Restated Certificate of Incorporation of
Registrant, previously filed as Exhibit 3.1 to Registration
Statement 33-84534 on Form S-4, which is incorporated herein by
reference, as amended by the Certificate of Merger, dated November
10, 1994, of ICN Pharmaceuticals, Inc., SPI Pharmaceuticals, Inc.
and Viratek, Inc. with and into ICN Merger Corp. previously filed as
Exhibit 4.1 to Registration Statement No. 333-08179 on Form S-3,
which is incorporated herein by reference.*
4.2
Bylaws of the Registrant previously filed as Exhibit 3.2 to
Registration Statement No. 33-84534 on Form S-4, which is
incorporated herein by reference.*
4.3
Form of Rights Agreement, dated as of November 2, 1994,
between the Registrant and American Stock Transfer & Trust Company,
as trustee, previously filed as Exhibit 4.3 to the Registrant's
Registration Statement on Form 8-A, dated November 10, 1994, which
is incorporated herein by reference.*
4.4
ICN Pharmaceuticals, Inc. Long-Term Incentive Plan previously
filed as Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q for the
quarter ended June 30, 1998, and incorporated herein by reference.*
5.1
Opinion of Coudert Brothers LLP regarding the legality of
shares of Common Stock covered by the Registration Statement.
23.1
Consent of Independent Accountants.
23.2
Consent of Coudert Brothers LLP (included in Exhibit 5.1).
24.1
Powers of Attorney (included on signature pages of this Registration Statement).
*Incorporated by Reference.